Yüklüyor......

Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis

SUMMARY: ‘Rebound’ or ‘withdrawal’ symptoms are frequently observed after a sudden discontinuation of clozapine. We describe a patient with treatment-resistant schizoaffective disorder who developed agranulocytosis on clozapine but was successfully switched to treatment with olanzapine with no deter...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BJPsych Open
Asıl Yazarlar: Green, Alastair, Stephenson, Thomas, Whiskey, Eromona, Shergill, Sukhi S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cambridge University Press 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6537554/
https://ncbi.nlm.nih.gov/pubmed/31530315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjo.2019.31
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!